Evidence map›Paper›PMID 41407382›Full record

ArticleThe Journal of veterinary medical science2026

Immunophenotypic characterization of canine oligodendroglioma cells cultured in an oligodendrocyte precursor cell-tailored medium.

Kio Yoshida, James K Chambers, Kei Kakishima, Kazuyuki Uchida

Abstract read
In one paragraph

Article in The Journal of veterinary medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kio YoshidaLaboratory of Veterinary Pathology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.
James K ChambersLaboratory of Veterinary Pathology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.
Kei KakishimaER Hachioji Advanced Animal Medical and Critical Care Center, Tokyo, Japan.
Kazuyuki UchidaLaboratory of Veterinary Pathology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Canine oligodendrogliomas express platelet-derived growth factor receptor alpha (PDGFRA), an oligodendrocyte precursor cell (OPC) marker. In this study, tumor cells derived from 3 French bulldogs with oligodendroglioma were cultured in conventional medium with 10% fetal bovine serum (FBS) and an OPC-tailored medium containing platelet-derived growth factor (PDGF)-AA and basic fibroblast growth factor (bFGF). Immunocytochemically, cells cultured with 10% FBS were negative for PDGFRA, but tended to express 2',3'-cyclicnucleotide 3'-phosphodiesterase (CNPase) and β3-tubulin. In contrast, the cells cultured with PDGF-AA and bFGF tended to express PDGFRA. These results suggest that canine oligodendroglioma cells cultured with PDGF-AA and bFGF exhibit OPC-like immunophenotype. Cells cultured with OPC-tailored medium may be useful for further in vitro research on canine oligodendrogliomas.

Indexed as

Brain NeoplasmsDog DiseasesOligodendrocyte Precursor CellsOligodendrogliomaAnimalsCell Culture TechniquesCulture MediaDogsFibroblast Growth Factor 2ImmunophenotypingPlatelet-Derived Growth FactorReceptor, Platelet-Derived Growth Factor alphaTumor Cells, CulturedCulture MediaFibroblast Growth Factor 2Platelet-Derived Growth Factorplatelet-derived growth factor AReceptor, Platelet-Derived Growth Factor alphacell culturedogfibroblast growth factoroligodendrogliomaplatelet-derived growth factor

Identifiers

PMID41407382
PMCPMC12887079

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.